Bibliography
Export 39 results:
Filters: Keyword is Immunosuppressive Agents / therapeutic use [Clear All Filters]
Acute Chagas' disease in postrenal transplant and treatment with benzonidazole. Ann Diagn Pathol. 2010;14(3):199-203.
Identifying predictors of central nervous system disease in solid organ transplant recipients with cryptococcosis. Transplantation. 2010;89(1):69-74.
Infections in heart transplant recipients in Brazil: the challenge of Chagas' disease. J Heart Lung Transplant. 2010;29(3):286-90.
Neurologic complications in adult living donor liver transplant patients: an underestimated factor? J Neurol. 2010;257(2):253-8.
Pretransplant cryptococcosis and outcome after liver transplantation. Liver Transpl. 2010;16(4):499-502.
Breakthrough Fusarium spp fungemia during caspofungin therapy in an ABO-incompatible orthotopic liver transplant patient. J Chemother. 2009;21(2):236-8.
Hydatid cyst disease in a renal allograft recipient. Saudi JKidney DisTranspl. 2009;20(6):1057-1060.
Organ recipients suffering from undifferentiated neuroendocrine small-cell carcinoma of donor origin: a case report. Transplant Proc. 2009;41(6):2639-42.
Human T-cell leukemia virus type I-associated myelopathy following living-donor liver transplantation. Liver Transpl. 2008;14(5):647-50.
Liver echinococcosis in a renal transplant patient: a particularly intriguing case report. JNephrol. 2008;21(3):442-445.
Chagas disease in a recipient of cord blood transplantation. Bone Marrow Transplant. 2007;39(2):127-8.
Pilot study of early corticosteroid elimination after pancreas transplantation. Transplant Proc. 2005;37(2):1287-8.
Severe hemolysis resulting from D incompatibility in a case of ABO-identical liver transplant. Transfusion. 2004;44(11):1635-9.
If the donor had an early-stage genitourinary carcinoma and the liver has already been implanted, should we perform the transplantectomy? Liver Transpl. 2003;9(12):1281-5.
Reduced-intensity bone marrow transplantation from an alternative unrelated donor for myelodysplastic syndrome of first-donor origin. Am J Hematol. 2003;72(3):220-2.
De novo sarcomas in solid organ transplant recipients. Transplant Proc. 2002;34(5):1786-7.
Kaposi sarcoma: an analysis of the US and international experiences from the Israel Penn International Transplant Tumor Registry. Transplant Proc. 2001;33(40762):3660-1.
Massive immune haemolysis after allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility. Br J Haematol. 2001;112(3):787-95.
A case of ABO-incompatible renal transplant patient with non-insulin-dependent diabetes mellitus; long-standing observation of serial glomerular change by protocol biopsy. Clin Transplant. 1999;13 Suppl 1:43-7.
Long-term follow-up of ABO-incompatible renal transplant recipients. Transplant Proc. 1999;31(40575):256-7.
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood. 1999;94(7):2208-16.
Advanced donor-origin melanoma in a renal transplant recipient: immunotherapy, cure, and retransplantation. Transplantation. 1998;66(5):655-661.
De novo malignances in pediatric organ transplant recipients. Pediatr Transplant. 1998;2(1):56-63.
Influence of immunosuppression in HTLV-1-positive renal transplant recipients. Transplant Proc. 1998;30(4):1324-6.